期刊文献+

收缩性心力衰竭患者血清脂联素与炎性反应介质及心功能的相关性研究 被引量:2

Investigation of the correlation between serum adiponectin and inflammatory reaction medium as well as cardiac function in patients with congestive heart failure
暂未订购
导出
摘要 目的测定收缩性心力衰竭(CHF)患者血清脂联素(Adp)、高敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的变化,分析Adp水平与炎性反应介质及心力衰竭严重程度的关系。方法选取2005年6月~2006年7月住院的CHF患者80例,健康对照组40例。CHF组按NYHA分级分为II、III、IV级。应用放射免疫法检测血清Adp,酶联免疫吸附法检测TNF-α、IL-6、hs-CRP。对CHF组心功能III、IV级患者行Swan-Ganz导管血流动力学检查测定心指数(CI)和肺毛细血管嵌压(PCWP)。结果CHF组患者血浆Adp浓度及hs-CRP、TNF-α、IL-6均明显高于健康对照组(P<0.01),且均随着NYHA分级程度的加重而显著增加(P<0.05)。Adp浓度与hs-CRP(r=-0.34,P<0.05)、TNF-α(r=-0.57,P<0.01)、IL-6(r=-0.52,P<0.01)呈显著负相关,与CI(r=0.36,P<0.05)呈显著正相关,与PCWP无相关性。CHF组III、IV级患者随心功能的快速改善,Adp浓度显著减少(P<0.01)。TNF-α为Adp水平的独立影响因素。结论随心力衰竭严重程度的增加,血清中脂联素浓度显著增加,并且与血清炎性介质呈显著负相关。随心功能的快速改善,Adp浓度显著减少。Adp在CHF病理生理过程中可能具有重要的抗炎性作用。 Objective To study the relationship between the levels of serum adiponectin (Adp), high-sensi- tive C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) and inflammatory reaction medium as well as the severity of heart failure in patients with congestive heart failure(CHF). Methods 80 patients with CHF admitted into our hospital from June 2005 to July 2006 were divided into 3 subgroups according to New York Heart Association (NYHA) functional class. 40 healthy subjects were used as control group. The serum levels of Adp was measured by radioimmunoassay. The serum levels of hs-CRP, TNF-α, IL-6 were detected by enzyme-linked immunosorbent assay (ELISA),and cardiac index (CI) and pulmonary capillary wedge pressure (PCWP) of cardiac hemodynamics were determined by Swan-Ganz catheterizationin patients with NYHA Ⅲ-Ⅳ. Results The serum Adp levels in CHF group were significantly increased according to the severity of NYHA class, as compared with those in control group ( P 〈 0.01). Similarly, serum levels of hs-CRP and TNF-α and IL-6 were significantly increased in accordance with the NYHA class, as compared with those in control group ( P 〈 0.01 ). The serum Adp levels were negatively correlated with those of hs-CRP ( r = - 0.34, P 〈 0.05) and TNF-α( r = - 0.57, P 〈 0.01) as well as IL-6 ( r = -0.52, P 〈 0.01), however, which were positively correlated with those of CI ( r = 0.36, P 〈 0.05), but there was no correlation with PCWP. In NYHA Ⅲ and Ⅳ subgroups, according to the prompt improvement in cardiac function, the levels of Adp was significantly reduced ( P 〈 0.01 ). By multiple regression analysis, serum TNF-α level (OR 3.2,95 %, CI 1.5-7.3, P=0.025) was an independent factor wich effected Adp concentration. Conclusion The serum Adp levels increase with the severity of CHF, moreover, they are negatively correlated with the serum levels of hs-CRP mad TNF-α as well as IL-6. The Adp may have an important anti-inflammatory effect du ring the pathological and physical process of CHF.
作者 李新 高继龙
出处 《疑难病杂志》 CAS 2007年第10期581-583,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 心力衰竭 收缩性 脂联素 炎性介质 C-反应蛋白 肿瘤坏死因子-α 白介素-6 Heart failure, congestive Adiponectin Inflammatory medium C-reactive protein Tumor ne-crosis factor-alpha Interleukin-6
  • 相关文献

参考文献11

  • 1George J,Patal S,Wexler D,et al.Circulating adiponectin concentrations in patients with congestive heatt failure[J].Heart,2006,92 (10):1 420-1424.
  • 2王淑芳,催莹,赵家军2.脂联素及其分泌调节[J].中国动脉硬化杂志,2005,13(2):242-244. 被引量:21
  • 3Ouchi N,Shibata R,Walsh K.Cardioprotection by adiponectin[J].Trends Cardiovasc Med,2006,16(5):141-146.
  • 4Pischon T,Rimm EB.Adiponectin:a promising marker for cardiovascular disease[J].Clin Chem,2006,52(5):797-799.
  • 5于明月,张扬,边树怀.脂联素研究进展[J].疑难病杂志,2006,5(3):230-232. 被引量:9
  • 6Ingelsson E,Riserus U,Berne C,et al.Adiponectin and risk of congestive heart failure[J].JAMA,2006,295(15):1 772-1 774.
  • 7von Eynatten M,Hamann A,Twardella D,et al.Relationship of adiponectin with markers of systemic inflammation,atherogenic dyslipidemia,and heart failure in patients with coronary heart disease[J].Clin Chem,2006,52 (5):853-859.
  • 8Shibata R,Ouchi N,Ito M,et al.Adiponectin-mediated modulation of hypertrophic signals in the heart[J].Nat Med,2004,10(6):1 384-1 389.
  • 9Guzik TJ,Mangalat D,Korbut R.Adipocytokines-novel link between inflammation and vascular function[J].J Physiol Pharmacol,2006,57 (4):505-528.
  • 10Nakamura T,Funayama H,Kubo N,et al.Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure[J].Circ J,2006,70(12):1 557-1 562.

二级参考文献47

  • 1Berg AH,Combs TP,Scherer PE.Acrp30/adiponectin:an adipocytokine regulating glucose and lipid metabolism.Trends Endocrinol Metabolism,2002,13(1):84-89.
  • 2Wang Y,Xu A,Knight C,Xu LY,Cooper GJ.Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin:potential role in the modulation of its insulin-sensitizing activity.J Biol Chem,2002,277(22):19 521-529.
  • 3Yoda-Murakami M,Taniguchi M,Takahashi K,Kawamata S,Saito K,Choi-Miura.Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver.Biochm Biophys Res,Commun,2001,285(2):372-377.
  • 4Pajvani UB,Hankins M,Combs TP,Rajala MW,Doebber T,Berger TP,et al.Complex distrbution,not absolute amount of adiponectin,correlates with thizolidinedione-mediated mprovement in insulin sensitivity.J Biol Chem,2004,279(13):12 152-162.
  • 5Pajvani UB,Du X,Combs TP,Berg AH,Rajala MW,Schulthess T,et al.Structure-Function Studies of the Adiponectin-Secreted Hormone Acrp30/Adiponectin.J Biol Chem,2003,278(11):9 073-085.
  • 6Tsao TS,Tomas E,Murrey HE,Hug C,Lee DH,Ruderman NB,et al.Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity.J Biol Chem,2003,278(50):50 810-817.
  • 7Yamauchi T,Kamon T,Minokoshi Y,Ito Y,Waki H,Uchidu S,et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.Nature Medicine,2002,8(11):1 288-295.
  • 8Wu X,Motoshima H,Mahadev K,Stalker TJ,Scalia R,Goldstein BJ.Involvement of Amp-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes.Diabetes,2003,52(2):1 355-363.
  • 9Yamanchi T,Kamon J,Ito Y,Tsuchida A,Yokomizo T,Kita S,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.Nature,2003,423(6491):762-769.
  • 10Chinetti G,Zamadski C,Fruchart JC,Zawdski C,Fruchart JC,Steels B.Expression of adiponectin receptor in human macrophages andregulation by agonists of the nuclear receptor PPARalpha,PPARgamma,and LXR.Biochem Biophys Res Commun,2001,314(1):151-158.

共引文献28

同被引文献18

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部